Pretraživanje
Prikaz rezultata 1-10 od 91
Angiogenic Factors eNOS and VEGF Have Increased Expression in Granulocytes of JAK2V617F Homozygous Forms of Polycythemia Vera
(Amer Soc Hematology, Washington, 2011)
Effect of iron intervention on growth during gestation, infancy, childhood, and adolescence: a systematic review with meta-analysis
(Oxford Univ Press Inc, Cary, 2013)
To evaluate the effect of iron intervention on physical growth in fetuses, infants, children, and adolescents up to 18 years of age, a systematic review with meta-analysis of randomized controlled trials (RCTs) was conducted. ...
EURRECA-Principles and Future for Deriving Micronutrient Recommendations
(Taylor & Francis Inc, Philadelphia, 2013)
The EURopean micronutrient RECommendations Aligned (EURRECA) Network of Excellence (NoE) explored an approach for setting micronutrient recommendations, which would address the variation in recommendations across Europe. ...
Incidence of anti-alfa fodrin antibodies in primary sjogren syndrome and its correlation with anti ro/SS-A and anti La/SS-B antibodies
(BMJ Publishing Group, London, 2006)
The s100 proteins as mediators of inflammation are increased in myeloproliferative neoplasm and downregulated by jak2 inhibition
(Ferrata Storti Foundation, Pavia, 2016)
The inhibition of jak/stat signaling is compensated by activation of mapk pathway in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2017)
Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: Seroprevalence and risk factors
(Elsevier Science Bv, Amsterdam, 2006)
Toxoplasmosis is a globally distributed zoonosis with a clinical impact in the unborn fetus and in the immunosuppressed individual. In Serbia, studies of risk factors for Toxoplasma gondii infection in humans have shown ...
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Haemodynamic effects of no and vitamin C supplementation in SHR with acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2006)